Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

Go back to Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
(NASDAQ: JAGX) Delayed: 0.35 -0.06 (14.63%)
Previous Close $0.41    52 Week High $4.60 
Open $0.43    52 Week Low $0.81 
Day High $0.43    P/E N/A 
Day Low $0.33    EPS $0.00 
Volume 419,524